HORMON RECEPTOR POSITIVE BREAST CANCER

Clinical trials for HORMON RECEPTOR POSITIVE BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new HORMON RECEPTOR POSITIVE BREAST CANCER trials appear

Sign up with your email to follow new studies for HORMON RECEPTOR POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo therapy aims to control advanced breast cancer longer

Disease control Not yet recruiting

This study is testing whether combining two drugs, camizestrant and ribociclib, can better control advanced hormone-positive breast cancer. It will involve about 150 adults whose cancer has progressed despite at least 5 years of prior hormone-blocking therapy. The main goal is to…

Matched conditions: HORMON RECEPTOR POSITIVE BREAST CANCER

Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

HORMON RECEPTOR POSITIVE BREAST CANCER

Get alerted when new HORMON RECEPTOR POSITIVE BREAST CANCER trials appear

New combo therapy aims to control advanced breast cancer longer